Malignant Lip and Oral Cavity Neoplasm — Trials

Malignant Lip and Oral Cavity Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

554 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 149
Recruiting: 77
Ph III recruiting: 11
Growth YoY: +4.8%
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: 26.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (53)

clinicaltrialsPublishedShowing 51–61 of 61 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06861712	Chemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal Cancer	not yet recruiting	Phase 2	50	Sun Yat-sen UniversityOTHER	1	Apr 25, 2025	clinicaltrials
NCT06728631	Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL	active not recruiting	Phase 2	22	Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER	1	Feb 24, 2025